Saturday 17 October 2026
Export FEMY’s income statement to Excel — free account
Femasys Inc.
FEMY Healthcare Medical Instruments & Supplies
Femasys Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 million, up 40.8% from fiscal 2024. In the quarter to June 2026, revenue fell 18.9%, EPS grew 58.4%, free cash flow grew 11.3% and total debt rose 3,369.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.65
0.09
−5.17%
Follow FEMY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 2 | 3 | 3 |
| (376.23%) | (455.80%) | (267.10%) | (443.65%) | ||
| (124.24%) | (112.32%) | (83.31%) | (94.25%) | ||
ROIC |
(12,042.89%) | (578.36%) | (175.17%) | (176.91%) | |
Return on Tangible Assets |
(573.23%) | (126.58%) | (111.61%) | (194.88%) | |
Average Days of Receivables |
101.31 | 98.13 | 26.46 | 23.97 | |
Free Cash Flow per Share |
(9.79) | (9.72) | (5.57) | (5.38) | |
Free Cash Flow |
(20.07) | (19.22) | (18.58) | (18.07) | |
Capital Expenditures |
(0.49) | (0.52) | (0.51) | (0.42) | |
| Other line items | |||||
Cash ROIC |
(217.47%) | (94.04%) | (111.86%) | (198.78%) | |
Accounts Receivable Turnover |
4.34 | 4.15 | 11.71 | 11.34 | |
Accounts Payable Turnover |
0.46 | 0.54 | 0.47 | 0.32 | |
Inventory Turnover |
0.20 | 0.20 | 0.18 | 0.16 | |
Average Days of Payables |
1,041.71 | 765.69 | 638.20 | 950.16 | |
Days of Inventory on Hand |
2,771.64 | 2,401.62 | 2,438.91 | 2,516.79 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
384.73% | 330.41% | 248.99% | 280.54% | |
Selling, General and Administrative Expense of Revenue |
519.87% | 483.55% | 486.18% | 529.69% | |
Share Based Compensation of Revenue |
41.61% | 34.45% | 24.17% | 26.24% | |
Interest Coverage |
(9.20) | (9.30) | (10.17) | (13.48) | |
Operating CF/Net income |
0.99 | 1.00 | 1.46 | 1.44 | |
Depreciation/Fixed assets |
0.19 | 0.18 | 0.08 | (0.03) | |
Capex/Depreciation |
(1.45) | (1.54) | (3.19) | 8.79 | |
Revenue per Share |
1.01 | 1.16 | 0.71 | 0.69 | |
Operating CF per Share |
(9.55) | (9.45) | (5.42) | (5.26) | |
Capex per Share |
(0.24) | (0.27) | (0.15) | (0.13) | |
Capex to Sales |
0.24 | 0.23 | 0.21 | 0.18 |
Columns are period end dates